The new Aperio ScanScope system allows for accelerated analyses of huge numbers of clinical tissue samples. While samples were previously examined on an individual basis using a conventional microscope, the Aperio ScanScope system is capable of scanning and analysing many hundreds of samples at a time. The new technology platform has a wide variety of uses and will accelerate the research process for Irish scientists exploring aspects of cancer, neurobiology and cardiovascular disease.
Dr Amanda McCann and Dr William Gallagher, both of UCD Conway Institute, and Professor Elaine Kay of Beaumont Hospital and the Royal College of Surgeons in Ireland received funding for this equipment through the Health Research Board (HRB) (). McCann, Gallagher and Kay, who have teamed up to develop and apply advanced imaging tools for histopathology, are making notable ground in their investigations into the causes and possible treatments for breast, bladder, and colorectal cancer. This award is testament to the success of their cross-institutional partnership, which is facilitated through the Dublin Molecular Medicine Centre (DMMC) and allows for collaborative translational research, which involves bringing observations made at the laboratory bench closer to implementation in the clinical setting.
Commenting at the unveiling the Aperio ScanScope system at UCD Conway Institute, Dr Anne Cody, Research Grants Manager, HRB said, “Translational research is a priority at the Health Research Board. This new equipment will increase the potential to get results quickly and will help improve diagnosis, prognosis and treatment of patients. We are pleased that this unique piece of equipment will also be offered to national and international users to maximise use - this will benefit even more patients.”
"This piece of equipment is set to revolutionise translational research at UCD Conway and at Beaumont Hospital and are certain that it will benefit the many research teams nationwide and from the UK who have already expressed interest in using the equipment to process their data”, said Dr Amanda McCann.
